Form 4: David O'Toole Increases RCEL Direct Holdings to 29,657 Shares

Rhea-AI Filing Summary

David O'Toole, identified as the Chief Financial Officer, filed a Form 4 reporting a change in beneficial ownership of Avita Medical, Inc. (RCEL). The filing shows he acquired 2,000 shares of common stock on 08/12/2025 at a price of $4.81 per share, increasing his direct holdings to 29,657 shares. The transaction is reported under transaction code P and the Form 4 was filed by one reporting person.

Positive

• Reported acquisition: David O'Toole purchased 2,000 shares at $4.81, increasing direct holdings to 29,657.
• Clear disclosure: Form 4 identifies the reporting person as CFO and was filed by one reporting person, with transaction date 08/12/2025.

Negative

• None.

Insights

Financial Analyst

TL;DR: Officer purchased a modest block of shares; the immediate market impact is likely limited.

The Form 4 documents a purchase of 2,000 shares at $4.81, raising direct holdings to 29,657 shares. For a public company, this size of purchase by a named officer is a straightforward insider acquisition disclosure. There are no derivative transactions or disposals reported. Based solely on the filing, the transaction appears routine and not material to company capital structure.

Corporate Governance Expert

TL;DR: Disclosure appears complete and timely for a single reporting officer.

The Form 4 names the reporting person, relationship (CFO), transaction date (08/12/2025), transaction code (P), number of shares acquired (2,000) and resulting direct ownership (29,657). The form indicates a single filer and shows no amendments. From a compliance perspective, the filing meets standard Section 16 disclosure elements contained in the document.

Insider Trade Summary

Net Buyer: 2,000 shares ($9,620)

Net Buy 1 txn

Insider O'Toole David D

Role CFO

Bought 2,000 shs ($10K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,000	$4.81	$10K

Holdings After Transaction: Common Stock — 29,657 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

O'Toole David D

(Last) (First) (Middle)

28159 AVENUE STANFORD

SUITE 220 - AVITA MEDICAL

(Street)

VALENCIA CA 91355

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVITA Medical, Inc. [ RCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2025		P		2,000	A	$4.81	29,657	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	David O'Toole	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Avita Medical (RCEL)?

David O'Toole, identified as the Chief Financial Officer, filed the Form 4.

What transaction is reported in the RCEL Form 4 dated 08/12/2025?

The filing reports the acquisition of 2,000 common shares on 08/12/2025 at a price of $4.81 per share, transaction code P.

How many Avita Medical (RCEL) shares does David O'Toole own after the reported transaction?

Following the reported transaction, his direct beneficial ownership is 29,657 shares.

Was the Form 4 filed jointly or by a single reporting person?

The Form 4 indicates it was filed by one reporting person.

Does the filing report any derivative securities or option transactions?

No. Table II for derivative securities contains no entries in this filing.